![Mark McDonnell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark McDonnell
Geen lopende functies
Health Technology
Profiel
Mark McDonnell worked as Chief Chemist at Neuropathix, Inc. Former job includes Chief Chemist at Neuropathix, Inc.
Eerdere bekende functies van Mark McDonnell
| Bedrijven | Functie | Einde |
|---|---|---|
| NEUROPATHIX, INC. | Corporate Officer/Principal | 01-09-2024 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Neuropathix, Inc.
 Neuropathix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapeutics for inflammatory & neuropathic pain related diseases | Health Technology |
